Lorianne Masuoka K. 4
4 · OPIANT PHARMACEUTICALS, INC. · Filed Jun 16, 2021
Insider Transaction Report
Form 4
Lorianne Masuoka K.
Director
Transactions
- Award
Common Stock
2021-06-15+2,000→ 2,000 total
Footnotes (1)
- [F1]2,000 shares are represented by restricted stock units ("RSUs"). Each RSU represents the Reporting Person's right to receive one share of Common Stock of Issuer, subject to the vesting schedule: 100% vest on the one year anniversary date or the date of the 2022 Annual Shareholder Meeting, whichever is earlier, subject to the Reporting Person continuing as a service provider through such date.